Home / Health / Exercise Boosts Weight Loss Drug Results
Exercise Boosts Weight Loss Drug Results
30 May
Summary
- Exercise combined with semaglutide enhanced fat loss in mice.
- The combo treatment improved body composition more effectively.
- Exercise supports muscle health and physical strength alongside medication.
Weight loss medications containing semaglutide have transformed obesity treatment by aiding appetite control and improving blood sugar. However, concerns exist about potential loss of lean muscle mass alongside fat. Recent research, presented at the European Atherosclerosis Society Congress 2026, indicates that combining semaglutide with exercise may offer a solution.
In a study involving mice, semaglutide alone reduced fat mass by 31% but also decreased lean mass by 11%. The combination of semaglutide and exercise achieved a more significant 45% fat mass reduction while limiting lean mass loss to 8%. This suggests exercise enhances fat loss and muscle preservation.
Beyond weight management, the dual approach improved insulin sensitivity and blood lipid levels. Exercise further reduced inflammation, liver fat, and atherosclerotic lesions. Crucially, the combined treatment led to significant improvements in muscle grip strength and fibre size, indicating enhanced physical function.
These findings, while from animal studies, underscore the importance of exercise in maximizing the benefits of weight loss medications and preserving muscle health. Experts emphasize that medication alone may not be sufficient for optimal outcomes.
